Leonard Freedman was named chief science officer at the Frederick National Laboratory for Cancer Research.
He joins the FNL staff after six years as founding president of the Global Biological Standards Institute, a nonprofit dedicated to advancing life science standards and best practices through policy initiatives. Previously, he served as vice dean for research and professor of biochemistry and molecular biology at Jefferson Medical College, Thomas Jefferson University.
As a vice president at Wyeth and executive director at Merck, Freedman also led discovery research efforts in the pharmaceutical industry. Previously, Freedman was a member and professor of cell biology and genetics at Memorial Sloan Kettering Cancer Center and Weil Cornell Medical College. There, Freedman and his laboratory made decisive discoveries in the area of nuclear hormone receptor structure and function.
